日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling

一项针对转移性胰腺癌的 XL888(HSP90 抑制剂)联合帕博利珠单抗的 Ib/II 期临床试验,并结合转化免疫分析。

Horvat, Natalie K; Diab, Maria; Phillips, Maggie J; McCook-Veal, Ashley; Grundy, Erin E; Alese, Olatunji B; Greene, Emily; Gbolahan, Olumide; Coleman, Kathleen; Doxie, Deon; Herting, Cameron J; Hammons, Jacklyn; Mahdi, Zaid; Switchenko, Jeffrey M; Paulos, Chrystal M; El-Rayes, Bassel F; Lesinski, Gregory B

Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data

非小细胞肺癌患者的生物标志物检测和治疗模式:国际肺癌研究协会对美国临床肿瘤学会CancerLinQ Discovery数据的分析

Behera, Madhusmita; Joseph, Gregory; Rupji, Manali; Huang, Zhonglu; Bunn, Becky; Wynes, Murry W; Switchenko, Jeffrey; Scagliotti, Giorgio V; Tsao, Ming S; Belani, Chandra P; Sequist, Lecia V; Ramalingam, Suresh S

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine

帕立骨化醇和羟氯喹增强胰腺导管腺癌化疗疗效的机制

Ganji Purnachandra Nagaraju ,Madhu Sudhana Saddala ,Jeremy B Foote ,Ateeq M Khaliq ,Ashiq Masood ,Yuvasri Golivi ,Dhana Sekhar Reddy Bandi ,Sujith Sarvesh ,Sudhir Putty Reddy ,Jeffrey Switchenko ,Julienne L Carstens ,Mehmet Akce ,Cameron Herting ,Olatunji B Alese ,Karina J Yoon ,Upender Manne ,Manoj K Bhasin ,Gregory B Lesinski ,Vikas P Sukhatme ,Bassel F El-Rayes

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine

帕立骨化醇和羟氯喹增强胰腺导管腺癌化疗疗效的机制

Ganji Purnachandra Nagaraju,Madhu Sudhana Saddala,Jeremy B Foote,Ateeq M Khaliq,Ashiq Masood,Yuvasri Golivi,Dhana Sekhar Reddy Bandi,Sujith Sarvesh,Sudhir Putty Reddy,Jeffrey Switchenko,Julienne L Carstens,Mehmet Akce,Cameron Herting,Olatunji B Alese,Karina J Yoon,Upender Manne,Manoj K Bhasin,Gregory B Lesinski,Vikas P Sukhatme,Bassel F El-Rayes

Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer

早期临床试验:IAP拮抗剂托利那泮联合根治性放疗治疗不适合顺铂治疗的晚期头颈癌患者

Schmitt, Nicole C; Stokes, William A; Bates, James E; Kinney, Brendan L C; Remick, Jill; McDonald, Mark W; Rudra, Soumon; Steininger, Madison; Oyewole, Mosope; Patel, Mihir R; Kaka, Azeem S; Gross, Jennifer H; Switchenko, Jeffrey; Steuer, Conor E; Shin, Dong M; Saba, Nabil F

XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial.

XL888 和 pembrolizumab 在 Ib/II 期临床试验中调节结直肠肿瘤的免疫环境

Phillips Maggie J, Alese Olatunji B, Horvat Natalie K, Greene Emily, Gbolahan Olumide B, Coleman Kathleen, Doxie Deon B, Parihar Vaunita, Mahdi Zaid K, McCook-Veal Ashley, Switchenko Jeffrey M, Diab Maria, Herting Cameron J, Paulos Chrystal M, El-Rayes Bassel F, Lesinski Gregory B

A registry-based approach for estimating county-level race disparities in breast cancer mortality: an analysis in Georgia

基于登记数据估算县级乳腺癌死亡率种族差异:以佐治亚州为例的分析

Nash, Rebecca; Switchenko, Jeffrey M; Ward, Kevin C; Maliniak, Maret L; Collin, Lindsay J; Moubadder, Leah; Kramer, Michael R; Lash, Timothy L; Gaglioti, Anne; Bayakly, Rana; McCullough, Lauren E

Reducing Postoperative Opioid Use: A Comparison of Open Versus Ultrasound-Guided Regional Anesthesia for Patients Undergoing Open Pancreatoduodenectomy

减少术后阿片类药物的使用:开放式胰十二指肠切除术患者开放式区域麻醉与超声引导区域麻醉的比较

Mavani, Parit T; Sok, Caitlin; Ajay, Pranay S; McPherson, Tarrant; Switchenko, Jeffrey; Kooby, David A; Shah, Mihir M

Risk factors and clinical outcomes of radiation-induced fistula after chemoradiation and image-guided brachytherapy for locally advanced cervical cancer

局部晚期宫颈癌放化疗及影像引导近距离放射治疗后放射性瘘的危险因素及临床结局

Ali, Naba; Sykes Martin, Katherine D; Tobillo, Rachel; Meiyappan, Karthik; McCook-Veal, Ashley; Switchenko, Jeffrey; Dresser, Sean; Dilley, Sarah; Starbuck, Kristen D; Khanna, Namita; Shelton, Joseph; Patel, Ashish; Eng, Tony; Manning-Geist, Beryl; Remick, Jill S

Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer

Polo 样激酶 1 抑制剂在小细胞肺癌临床前模型中表现出体外和体内疗效

Guojing Zhang, Abbe Pannucci, Andrey A Ivanov, Jeffrey Switchenko, Shi-Yong Sun, Gabriel L Sica, Zhentao Liu, Yufei Huang, John C Schmitz, Taofeek K Owonikoko